Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction

Journal of Nuclear Medicine

Volumn 49, Issue 8, 2008, Pages 1277-1282

  Su, Jin Lee ^a   Young, Keun On ^a   Eun, Jeong Lee ^a   Joon, Young Choi ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

18F FDG PET; Atherogenic risk factor; Atherosclerosis; Risk modification

Indexed keywords

CHOLESTEROL; FLUORODEOXYGLUCOSE F 18; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RADIOPHARMACEUTICAL AGENT;

ADULT; AORTA; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DRUG UPTAKE; FEMALE; HUMAN; ILIAC ARTERY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; VASCULAR LESION; AGED; BLOOD; COMMON CAROTID ARTERY; CORONARY ARTERY DISEASE; METABOLISM; MIDDLE AGED; SCINTISCANNING;

AGED; CAROTID ARTERY, COMMON; CORONARY ARTERY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48749119873     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.052233     Document Type: Article

References (21)

1. Goldschmidt-Clermont PJ, Creager MA, Losordo DW, Lam GK, Wassef M, Dzau VJ. Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation. 2005;112:3348-3353.
2. Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297:499-508.
3. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation. 2006;113:2548-2555.
4. Brown BG, Zhao X, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993;87:1781-1789.
5. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953-957.
6. Alavi A, Kung JW, Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med. 2004;34:56-69.
7. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
9. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837.
10. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
11. Dunphy MP, Freiman A, Larson SM, Strauss HW. Association of vascular 18FFDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
12. Yun M, Jang S, Cucchiara A, Newberg AB, Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;32:70-76.
13. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533-1539.
14. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
15. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
16. Chironi G, Pagnoux C, Simon A, et al. Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis. Heart. 2007;93:96-99.
17. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-896.
18. Denke MA. Diet and lifestyle modification and its relationship to atherosclerosis. Med Clin North Am. 1994;78:197-223.
19. Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun. 2001;22:747-753.
20. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
21. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109:III8-III14.